Interest of Beta-2-Microglobilin Plasma Assay in Iterative Haemodialysis in the Nephrology and Haemodialysis Department of University Teaching Hospital of Point G, Bamako, Mali
- 1 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 2 Nephrology Unit of the Fousseyni DAOU Hospital in Kayes, Kayes, Mali
- 3 Faculty of Medicine of Bamako, Bamako, Mali
- 4 Faculty of Medicine of Bamako, Bamako, Mali
- 5 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 6 Nephrology Unit of Ségou Hospital, Ségou, Mali
- 7 Nephrology Unit of the Mali GAVARDO Hospital of Sébénicoro, Bamako, Mali
- 8 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 9 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 10 Nephrology Unit of Sikasso Hospital, Sikasso, Mali
- 11 Nephrology Unit of Sikasso Hospital, Sikasso, Mali
- 12 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 13 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 14 Nephrology and Haemodialysis Department of the University Teaching Hospital of Point-G, Bamako, Mali
- 15 Nephrology Unit of Somino DOLO Hospital in Mopti, Mopti, Mali
Abstract
Beta-2-microglobulin (B2M) is a low molecular weight polypeptide (11,800 Da) that exists in a free form and a form bound to cell membranes (light chains of HLA class I molecules). Their dosage is used in the exploration and monitoring of renal function in haemodialysis patients, hence the interest of this study, the objective of which is to study the different players involved in the increase of beta-2-microglobulin. Materials and Methods: This was a prospective and descriptive study from January 1 st , 2017 to August 31, 2017 (08 months). All patients with chronic hemodialysis for 3 years or more were included. We analyzed sociodemographic, clinical and paraclinical data. Results: We collected 50 patients. The mean age was 50 ± 4.6 years with extremes of 30 and 82 years. The female sex predominated (52%). Chronic end-stage renal failure was hypertensive (86%), diabetic (4%). All patients benefited from intermittent hemodialysis for 8 hours per week using a low permeability membrane (cuprophane). The average duration of hemodialysis was 68 ± 6.4 months with extremes of 36 and 204 months. Twenty percent (20%) and four percent (4%) of chronic dialysis patients had joint pain and sensory deficit. Phalen’s sign was positive in 2% (1 case), Tinel’s sign in 2% (1 case) and carpal tunnel syndrome in 2% (1 case). The mean serum beta-2-microglobulin level was 58.34 ng/l with extremes of 16.99 and 112.24 ng/l. There was a correlation between hypertensive nephropathies and beta-2-microglobulin levels above 50 ng/l (P < 0.001). The mortality rate was 6%. Conclusion: Our study has objectified factors such as inadequate dialysis (8 hours/week), use of low permeability membrane in the increase of beta-2-microglobulin. The increase in serum beta-2-microglobulin levels in our patients is evidence of poor purification of medium molecules. Its reduction can be established by improving the quality of dialysis, in particular by using a high-permeability membrane.
- Berggard, I. and Beearn, A.G. (1968) Isolation and Properties of a Low Molecular Weight Beta-2-Globulin Occurring in Human Biological Fluids. Journal of Biological Chemistry, 243, 4095-4103.
- Duprat, E. (2004) MHC-Like Proteins: Phytogenesis, Structure, IGH Functions (IMGT)-LIRMM 2004. PhylogenyWorking Group Seminarsorganized by the MAB Team.
- Chary-Valckenaere, I. (2001) Contribution to the Pathophysiology of Dialysis Arthropathy-Aluminium and Beta-2-Microglobulin Amyloidosis. Thesis Med Nancy.
- Anociar, M.R., Idmoursa, A., El Jahiri, Y., Boukhira, A., Beraou, A. and Chella, S. (2011) Interest in Determination of Beta-2-Microglobulin in Biological Samples. Revue Francophone des Laboratoires, 436, 77-82. https://doi.org/10.1016/S1773-035X(11)71160-1
- Kuchle, C., Fricke, H., Held, E. and Schiff, H. (1996) High-Flux Hémodialysis Postpones Clinical Manifestation of Dialysis-Related Amyloidosis. American Journal of Nephrology, 16, 484-488. https://doi.org/10.1159/000169048
- Cheung, A.K., Greene, T., Leypoldt, J.K., et al. (2008) Association between Serum β2-Microglobulinlevel and Infectorious Mortality in Hémodialysis Patients. Clinical Journal of the American Society of Nephrology, 3, 69-77. https://doi.org/10.2215/CJN.02340607
- Al-Taee, I.K., Al-Safar, J.J., Al-Falahi, Y.S. and Al-Shanima, I.A. (2003) The Clinical Significance of Béta2-Microglobulineinend Stage Renal Disease. Saudi Journal of Kidney Disease and Transplantation,14, 492-496.
- Alhomrany, M.A., Khan, M.R., Adzakut, F. and Hardnig, M.G. (2001) Carpel Tunnel Syndrome in Hemodialysis Patients: Early Detection by electro Neurophysiological Studies. Nephrology, 6, 259-262. https://doi.org/10.1046/j.1440-1797.2001.00061.x
- Okuno, S., Ishimura, E. and Kohno, K. (2009) Serum β2-Microglobuline Level Is a Significant Predictor of Mortality in Maintenance Hémodialysis Patients. Nephrology Dialysis Transplantation, 24, 577-577. https://doi.org/10.1093/ndt/gfn521
- M’Barki, H. (2011) Carpal Tunnel Syndromes in Chronic Hemodialysis Patients. Thesis Med, Fes, No. 119/11.
- Klappacher,G., Mundigler, G., Papousek, A., et al. (1993) Elevated Circulating Levels of Beta 2-Microglobuline in Patients with Idiopathie Dilated Cardiomyopathy. American Journal of Cardiology, 71, 119-121. https://doi.org/10.1016/0002-9149(93)90723-P
- Ouesada, J., Alouso, J., Gonzalez, J., Muñoz, R., Jans, I., Martiu, A. and Bouillon, R. (1998) Serum β-2-Microglobulin Is a Marker of High Bone Remodelling in Elderly Women. Mechanisms of Ageing and Development, 102, 293-298. https://doi.org/10.1016/S0047-6374(98)00019-0